2026-09930
Details
The document's own metadata, straight from the source system.
- Title
- 2026-09930
- Posted
- May 18, 2026
- Comment period
- May 18, 2026 – Jul 18, 2026
- FR Doc
- 2026-09930
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jul 17, 2026Mateo KreshaOpposeIndividual
The commenter urges the DEA to deny Benuvia Operations, LLC.'s application to manufacture mescaline. They argue that commercial manufacturing poses a threat to human health, violates the American Indian Freedom of Religion Act, and endangers the conservation of the Peyote plant.
Read comment → - Jul 17, 2026Comment on FR Doc # 2026-09930OpposeIndividual
The commenter, identifying as a Native American, opposes the decriminalization of peyote and mescaline and the production of synthetic mescaline. They argue that these substances are sacred to their culture and that the proposed actions threaten their religious ceremonies and violate the American Indian Religious Freedom Act of 1994.
Read comment → - Jul 15, 2026L.C. AllenOpposeIndividual
An individual citizen opposes the DEA's application to manufacture mescaline, citing concerns over human health, the future of Peyote, and violations of the American Indian Freedom of Religion Act. The commenter urges the DEA to prioritize public opinion over pharmaceutical production.
Read comment → - Jul 15, 2026Grace SesmaOpposeIndividual
The commenter urges the DEA to deny Benuvia Operations, LLC.'s application to manufacture mescaline. They argue that expanding commercial production poses a threat to human health, endangers the Peyote plant, and violates the American Indian Freedom of Religion Act.
Read comment →